Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Attempting to Identify Bacterial Allies in Immunotherapy of NSCLC Patients.
Grenda A, Iwan E, Krawczyk P, Frąk M, Chmielewska I, Bomba A, Giza A, Rolska-Kopińska A, Szczyrek M, Kieszko R, Kucharczyk T, Jarosz B, Wasyl D, Milanowski J. Grenda A, et al. Among authors: jarosz b. Cancers (Basel). 2022 Dec 19;14(24):6250. doi: 10.3390/cancers14246250. Cancers (Basel). 2022. PMID: 36551735 Free PMC article.
Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes.
Krawczyk P, Jarosz B, Kucharczyk T, Grenda A, Reszka K, Pankowski J, Wojas-Krawczyk K, Nicoś M, Szumiło J, Trojanowski T, Milanowski J. Krawczyk P, et al. Among authors: jarosz b. Oncotarget. 2017 Jul 31;8(38):64283-64293. doi: 10.18632/oncotarget.19724. eCollection 2017 Sep 8. Oncotarget. 2017. PMID: 28969070 Free PMC article.
Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients.
Grenda A, Krawczyk P, Błach J, Chmielewska I, Kubiatowski T, Kieszko S, Wojas-Krawczyk K, Kucharczyk T, Jarosz B, Paśnik I, Borowiec-Bar M, Frąk M, Kieszko R, Szczyrek M, Reszka K, Krukowska K, Kolak A, Mańdziuk S, Kowalski D, Sawicki M, Świniuch D, Starosławska E, Ramlau R, Szumiło J, Krzakowski M, Milanowski J. Grenda A, et al. Among authors: jarosz b. Front Oncol. 2021 Feb 8;10:563613. doi: 10.3389/fonc.2020.563613. eCollection 2020. Front Oncol. 2021. PMID: 33628725 Free PMC article.
Discrepancies between ALK protein disruption and occurrence of ALK gene rearrangement in Polish NSCLC patients.
Grenda A, Jarosz B, Krawczyk P, Kucharczyk T, Wojas-Krawczyk K, Reszka K, Krukowska K, Nicoś M, Pankowski J, Bryl M, Ramlau R, Kuźnar-Kamińska B, Grodzki T, Szczęsna A, Siemiątkowska K, Szumiło J, Batura-Gabryel H, Palonka M, Milanowski J. Grenda A, et al. Among authors: jarosz b. J Thorac Dis. 2018 Aug;10(8):4994-5009. doi: 10.21037/jtd.2018.07.28. J Thorac Dis. 2018. PMID: 30233874 Free PMC article.
PD-L1 gene copy number and promoter polymorphisms regulate PD-L1 expression in tumor cells of non-small cell lung cancer patients.
Krawczyk P, Grenda A, Wojas-Krawczyk K, Nicoś M, Kucharczyk T, Jarosz B, Reszka K, Pankowski J, Krukowska K, Bożyk A, Szumiło J, Sawicki M, Trojanowski T, Milanowski J. Krawczyk P, et al. Among authors: jarosz b. Cancer Genet. 2019 Sep;237:10-18. doi: 10.1016/j.cancergen.2019.06.001. Epub 2019 Jun 8. Cancer Genet. 2019. PMID: 31447062
Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma.
Grenda A, Krawczyk P, Kucharczyk T, Błach J, Reszka K, Chmielewska I, Buczkowski J, Kieszko R, Siwiec J, Kubiatowski T, Bożyk A, Krukowska K, Jarosz B, Paśnik I, Pankowski J, Świniuch D, Stencel K, Gil M, Lew K, Ramlau R, Szczęsna A, Fidler S, Sieracki A, Każarnowicz A, Serwatowski P, Grodzki T, Milanowski J. Grenda A, et al. Among authors: jarosz b. Oncol Lett. 2021 Jun;21(6):449. doi: 10.3892/ol.2021.12710. Epub 2021 Apr 7. Oncol Lett. 2021. PMID: 33868487 Free PMC article.
78 results